GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan · Delayed Price · Currency is TWD 17.35
-0.20 (-1.14%)
Aug 26, 2026, 1:30 PM CST
GeneReach Biotechnology Market Cap
GeneReach Biotechnology has a market cap or net worth of 994.21 million as of August 26, 2026. Its market cap has decreased by -11.89% in one year.
Market Cap
994.21M
Enterprise Value
820.50M
Revenue
238.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.35
ChartMarket Cap Chart
Since November 19, 2012, GeneReach Biotechnology's market cap has decreased from 1.27B to 994.21M, a decrease of -21.88%. That is a compound annual growth rate of -1.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 994.21M | -8.35% |
| Dec 31, 2025 | 1.08B | -34.10% |
| Dec 31, 2024 | 1.65B | -27.38% |
| Dec 29, 2023 | 2.27B | -25.28% |
| Dec 30, 2022 | 3.03B | -20.04% |
| Dec 30, 2021 | 3.79B | -27.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 1.18B |
| Enimmune | 1.16B |
| LabTurbo Biotech | 1.11B |
| BiOptic | 1.10B |
| Bio Preventive Medicine | 1.09B |
| Level Biotechnology | 1.02B |
| TCI GENE | 940.60M |
| Holy Stone Healthcare | 915.26M |